Anatomic Pathology Market to Reach $17.7 Billion by 2035

Anatomic pathology market was valued at $8.2 billion in 2025 and is projected to reach $17.7 billion by 2035, expanding at a CAGR of 8.0% from 2026 to 2035. Market growth is associated with the increasing volume of cancer diagnoses and the adoption of automated and digital pathology technologies across hospitals and diagnostic laboratories. According to the World Health Organization (WHO) Global Status Report on Cancer 2026, an estimated 20.6 million people were diagnosed with cancer worldwide in 2024, with annual cancer cases projected to reach nearly 35 million by 2050. This expanding diagnostic burden increases the requirement for tissue examination and pathology-based classification, supporting demand for instruments, consumables, reagents and kits used in histopathology, cytopathology, immunohistochemistry and molecular pathology workflows.

Browse the full report description of “Anatomic Pathology Market Size, Share & Trends Analysis Report, By Product Type (Instruments, Consumables, Reagents & Kits), By Technology (Histopathology, Cytopathology, Immunohistochemistry (IHC), Molecular Pathology, Digital Pathology), By Application (Cancer Diagnosis, Infectious Disease Diagnosis, Cardiovascular Diseases, Other Diseases), By End User (Hospitals, Diagnostic Laboratories, Academic & Research Institutions, Other Healthcare Facilities), Forecast Period (2026–2035))” at https://www.omrglobal.com/industry-reports/anatomic-pathology-market-size

Technology adoption is also changing anatomic pathology workflows, particularly through digital pathology, molecular pathology and image analysis. The International Agency for Research on Cancer (IARC) states that its current WHO Classification of Tumours integrates histopathological diagnosis with digital and molecular pathology, while digital pathology and image analysis are providing quantitative information for diagnostic assessment. The U.S. Food and Drug Administration (FDA) defines digital pathology as the scanning, visualization, analysis, transfer, storage, and interpretation of digitized pathology tissue data and has established a dedicated regulatory program for digital pathology medical devices. The FDA database also lists Roche Digital Pathology Dx as a whole-slide imaging system under pathology medical devices, reflecting the continued commercialization of digital tissue-imaging technologies. These developments are shifting pathology laboratories toward integrated workflows that combine conventional tissue preparation with digital imaging and computational analysis, supporting the expansion of the anatomic pathology product market.

Consumables Segment Leads the Anatomic Pathology Market

The consumables segment represents a major component of the anatomic pathology market because tissue diagnosis requires recurring use of slides, cassettes, microtome blades, stains, fixatives, processing reagents, paraffin, and other specimen-preparation materials. Unlike instruments, these products are consumed during routine laboratory workflows and therefore generate repeat purchasing requirements as pathology laboratories process tissue specimens. Sakura Finetek’s current product portfolio includes microtome blades, microscope slides, H&E staining kits, fixatives, tissue-processing reagents, paraffin, and xylene, covering multiple stages from specimen processing and sectioning to staining.

The underlying diagnostic workload also supports recurring requirements for pathology consumables. The latest WHO/IARC global cancer estimates reported 20 million new cancer cases and 9.7 million cancer deaths in 2022, while WHO’s 2026 cancer update indicates that annual new cancer diagnoses reached 20.6 million in 2024 and are projected to approach 35 million annually by 2050. The increasing volume of tissue specimens associated with cancer diagnosis requires continued use of consumables throughout fixation, processing, embedding, sectioning, and staining workflows

Recent Developments

• In April 2025, Roche received FDA Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device, combining IHC with AI-based digital pathology to quantify TROP2 expression in non-small cell lung cancer tissue. The development supports more precise tissue diagnosis and treatment selection within anatomic pathology workflows.
• In January 2025, Roche received S. FDA 510(k) clearance for the VENTANA DP 600 slide scanner, adding the high-capacity system to its Roche Digital Pathology Dx platform. The scanner can process up to 240 slides and produces high-resolution digital images of stained tissue samples for clinical diagnosis. The development expands digital whole-slide imaging capabilities within anatomic pathology laboratories and supports the use of digital workflows for tissue-based cancer diagnosis.

Market Coverage

• The market size available for 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segments Covered-
• By Product Type
• By Technology
• By Application
• By End User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape – Hoffmann-La Roche Ltd. (VENTANA), Danaher Corporation (Leica Biosystems), PHC Holdings Corporation (Epredia), Agilent Technologies, Inc. (Dako), and Hologic, Inc., Sakura Finetek Japan Co., Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anatomic Pathology Market Report Segment

Product Type

• Instruments
• Consumables
• Reagents & Kits

Technology

• Histopathology
• Cytopathology
• Immunohistochemistry (IHC)
• Molecular Pathology
• Digital Pathology

Application

• Cancer Diagnosis
• Infectious Disease Diagnosis
• Cardiovascular Diseases
• Other Diseases

End User

• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutions
• Other Healthcare Facilities

Anatomic Pathology Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anatomic-pathology-market-size